|

STRO-004 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Sutro Biopharma, Inc.1

Indications

  • Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Head and Neck Squamous Cell Carcinoma (HNSCC)1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Endometrial Cancer1
  • Urothelial Cancer1

Denver, Colorado1 trial

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

SCRI Denver

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.